AstraZeneca PLC (AZN)
63.20
-0.60
(-0.94%)
USD |
NASDAQ |
Nov 20, 16:00
63.82
+0.62
(+0.98%)
Pre-Market: 09:22
AstraZeneca Price to Book Value: 4.812 for Nov. 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.812 |
| November 19, 2024 | 4.858 |
| November 18, 2024 | 4.827 |
| November 15, 2024 | 4.815 |
| November 14, 2024 | 4.953 |
| November 13, 2024 | 4.972 |
| November 12, 2024 | 4.964 |
| November 11, 2024 | 4.934 |
| November 08, 2024 | 4.911 |
| November 07, 2024 | 4.926 |
| November 06, 2024 | 4.862 |
| November 05, 2024 | 5.046 |
| November 04, 2024 | 5.439 |
| November 01, 2024 | 5.438 |
| October 31, 2024 | 5.418 |
| October 30, 2024 | 5.546 |
| October 29, 2024 | 5.728 |
| October 28, 2024 | 5.788 |
| October 25, 2024 | 5.715 |
| October 24, 2024 | 5.780 |
| October 23, 2024 | 5.859 |
| October 22, 2024 | 5.888 |
| October 21, 2024 | 5.897 |
| October 18, 2024 | 5.959 |
| October 17, 2024 | 5.941 |
| Date | Value |
|---|---|
| October 16, 2024 | 5.963 |
| October 15, 2024 | 5.928 |
| October 14, 2024 | 5.947 |
| October 11, 2024 | 5.890 |
| October 10, 2024 | 5.853 |
| October 09, 2024 | 5.902 |
| October 08, 2024 | 5.853 |
| October 07, 2024 | 5.853 |
| October 04, 2024 | 5.899 |
| October 03, 2024 | 5.934 |
| October 02, 2024 | 6.060 |
| October 01, 2024 | 5.990 |
| September 30, 2024 | 5.932 |
| September 27, 2024 | 6.091 |
| September 26, 2024 | 6.135 |
| September 25, 2024 | 6.085 |
| September 24, 2024 | 6.032 |
| September 23, 2024 | 6.053 |
| September 20, 2024 | 6.151 |
| September 19, 2024 | 6.191 |
| September 18, 2024 | 6.166 |
| September 17, 2024 | 6.162 |
| September 16, 2024 | 6.202 |
| September 13, 2024 | 6.142 |
| September 12, 2024 | 6.196 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.211
Minimum
Dec 10 2021
13.47
Maximum
May 13 2020
7.469
Average
6.106
Median
Price to Book Value Benchmarks
| GSK PLC | 3.630 |
| Amgen Inc | 20.56 |
| Johnson & Johnson | 5.254 |
| Sanofi SA | 1.537 |
| Moderna Inc | 1.192 |
Price to Book Value Related Metrics
| PE Ratio | 30.31 |
| PS Ratio | 3.857 |
| PEG Ratio | 3.023 |
| Price to Free Cash Flow | 29.23 |
| Price | 63.20 |
| Earnings Yield | 3.30% |
| Market Cap | 195.96B |
| PEGY Ratio | 2.449 |
| Operating PE Ratio | 18.36 |
| Normalized PE Ratio | 25.52 |